Raised Series A led by Yuanhang Capital
融資輪次重大已核實
Guangzhou developer of the Zhuofeng micron-precision ophthalmic surgical robot (English name Oculotronics); Series A of close to CNY 100M (~US$14M) led by Yuanhang Capital (June 2026).
暫無精選機器人影片
暫無影片
該公司尚未關聯精選機器人影片。
| 年份 | 事件 | 來源 |
|---|---|---|
| 2026 | Closed a Series A of close to ¥100 million (about US$14 million; listed as US$15 million in the Robotics Series A 2026 ranking) in June 2026, led by Yuanhang Capital (元航资本) with follow-on from Minggui Capital (明桂资本) and other institutions; announced with the completion of China's first multicentre randomised registration trial for an ophthalmic surgical robot. | 來源 |
| 2025 | Took part in the world's first remote robot-assisted subretinal injection, Guangzhou to Urumqi over 5G (about 4,200 km), with Zhongshan Ophthalmic Center. | 來源 |
| 2023 | Raised a Pre-A round of tens of millions of yuan in November 2023 from Suizi Wealth, Minggui Capital and others. | 來源 |
| 2020 | Founded in Nansha, Guangzhou (registered 14 December 2020). | 來源 |
Oculotronics 微眸医疗的有日期變更紀錄,每條均附來源。
Raised Series A led by Yuanhang Capital
Xia Jun 夏俊 (Legal representative)